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Biological functions of nuclear proteins are regulated by post-
translational modifications (PTMs) that modulate gene expres-
sion and cellular physiology. However, the role of O-linked gly-
cosylation (O-GalNAc) as a PTM of nuclear proteins in the
human cell has not been previously reported. Here, we exam-
ined in detail the initiation of O-GalNAc glycan biosynthesis,
representing a novel PTM of nuclear proteins in the nucleus of
human cells, with an emphasis on HeLa cells. Using soluble
nuclear fractions from purified nuclei, enzymatic assays, fluo-
rescence microscopy, affinity chromatography, MS, and FRET
analyses, we identified all factors required for biosynthesis of
O-GalNAc glycans in nuclei: the donor substrate (UDP-GalNAc),
nuclear polypeptideGalNAc -transferase activity, and aGalNAc
transferase (polypeptide GalNAc-T3). Moreover, we identified
O-GalNAc glycosylated proteins in the nucleus and present
solid evidence for O-GalNAc glycan synthesis in this organelle.
The demonstration of O-GalNAc glycosylation of nuclear pro-
teins in mammalian cells reported here has important implica-
tions for cell and chemical biology.
The nucleus is one of the most important structures of
eukaryotic cells. This complex organelle stores the chromo-
somes and also regulates their duplication, segregation, repair,
and expression through a series of specific processes. The cell’s
biological information is saved and transferred within the
nucleus by three types of biopolymer molecules: DNA, RNA,
and proteins (1). Proteins play crucial roles in nuclear scaffold-
ing, DNA assembly, replication, transcription, and transport of
molecules. The biological activity of proteins is directly modu-
lated by their conformation, and changes in protein conforma-
tion are controlled mainly by post-translational modifications
(PTMs).3 The common PTMs of nuclear proteins are acetyla-
tion, sumoylation, phosphorylation, long-chain fatty acid con-
jugation, and glycosylation. A given PTM adds a tag to proteins
that can be recognized by specificmolecules (e.g. bromodomain
for acetyl residue; lectin for glycan) as a trigger of biological
effect (2, 3). Thus, biological functions of nuclear proteins can
be regulated via PTMs. PTMs of nuclear proteins play a central
role in epigenetic physiology, i.e.modulation by environmental
factors of cellular phenotype other than by the effects of genetic
encoding of information.
Glycosylation is the most common PTM of proteins; 50%
of cellular proteins are potential targets of glycosylation. Pro-
tein O-GlcNAc glycosylation (biosynthesis of O-GlcNAc gly-
cans) occurs in the nucleus, cytoplasm, and mitochondria (4).
O-GlcNAc is added by multiple alternatively spliced isoforms
of the enzymeGlcNAc transferase (OGT), which have different
intracellular localizations (5). There are three major OGT iso-
forms: nucleocytoplasmic OGT, short OGT, and mitochon-
drial OGT. Nucleocytoplasmic OGT and short OGT are local-
ized in the nucleus and cytoplasm, whereas mitochondrial
OGT is present in the mitochondrial matrix. O-GlcNAcase, a
glycosidase that removes O-GlcNAc from proteins, functions
in a cycling fashion with OGT. OGT acts as an epigenetic
“writer,” whereasO-GlcNAcase acts as an “eraser” of this PTM
by modulating biological activity of relevant nuclear proteins
such as histones, RNA polymerase II, and transcription factors.
TheO-GlcNAc PTM thus plays a crucial role in nuclear home-
ostasis (6). The hexosamine biosynthesis pathway generates
UDP-GlcNAc and UDP-GalNAc from glucose (Glc), acetyl-
CoA, ATP, uridine, and amino acids (7). The UDP-hexosamine
level thus depends onGlc concentration as well as salvage path-
ways of GalNAc and GlcNAc.O-GlcNAc glycan biosynthesis is
affected by metabolic diseases (notably diabetes) in which Glc
concentration is altered (8).O-GlcNAc glycosylation of nuclear
proteins has a major effect on altered transcription in diabetes
(9).
O-GalNAc glycans are the second most common glycan
structures on secreted proteins, after N-glycans. Their biosyn-
thesis is initiated by action of a multigene family of enzyme
polypeptide–N-acetylgalactosaminyltransferases (ppGalNAc-
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Ts) promoting covalent linkage of GalNAc from UDP-GalNAc
donor to Ser/Thr of acceptor, yielding GalNAc1-O-Ser/Thr
(10). Twenty members of the ppGalNAc-T family have been
found in humans. The initial step of O-GalNAc glycosylation
is critical in defining the amino acid position of PTM on
the protein and in facilitating subsequent monosaccharide
incorporation. The second monosaccharide linked to
GalNAc1-O-Ser/Thr may be galactose (Gal) or N-acetylg-
lucosamine (GlcNAc) yielding core 1 (Gal3GalNAc1-O-
Ser/Thr) or core 3 (GlcNAc3GalNAc1-O-Ser/Thr) gly-
can, respectively. The core structures are extended by action
of specific glycosyltransferases to generate complex O-
GalNAc glycans, which are synthesized mainly in Golgi (11).
Truncated O-GalNAc glycans are commonly synthesized by
epithelial tumor cells with overexpression of GalNAc1-O-
Ser/Thr (Tn antigen) or Gal3GalNAc1-O-Ser/Thr (T
antigen) residues, possibly by deletion or loss of the glyco-
syltransferases elongating Tn or T antigens (12, 13), and play
crucial roles in cell adhesion during the process of metastasis
(14).
We examined O-GalNAc glycan biosynthesis in the nucleus
of human cells as a PTM of nuclear proteins that may play an
important role in regulating their functions. Our focus was the
identification of all factors in the cell nucleus necessary for ini-
tiation of O-GalNAc glycan biosynthesis: the sugar donor sub-
strate, the nuclear polypeptide GalNAc-transferase activity, an
enzyme (polypeptide GalNAc-T3), and O-GalNAc–glycosylated
proteins (the products of glycan biosynthesis).
Results
UDP-GalNAc in cell nucleus
To examine nuclear localization of several molecules, we
purified HeLa cell nuclei as described previously (15). Nuclei
were separated from the cytoplasmofwhole cells usingNonidet
P-40 detergent in appropriate buffer and by centrifugation.
Purified nuclei were obtained by several washes with buffer
without detergent (Fig. 1), placed in hypertonic buffer, and son-
icated for disruption of nuclear membrane, and the soluble
nuclear fraction (nucleoplasm) was obtained by centrifugation.
Quality of purified nucleiwas evaluated by confocalmicroscopy
andWestern blotting (WB) with molecular markers of cellular
organelles: Golgin97 (Golgi), calreticulin (ER), tubulin (cyto-
plasm), and histone H3 (nucleus). Each of these methods
revealed high levels of nuclearmarkers (PI and histone) in puri-
fied nuclei or nucleoplasm but minimal levels of cytoplasm,
Golgi, and ER markers. This finding indicated that the method
used for purification of nuclei was appropriate.
Biosynthesis of nucleotide sugars such as UDP-GalNAc
occurs in the cytoplasm (16). UDP-GalNAc is the sugar donor
substrate required for ppGalNAc-T reaction. To examine the
presence of this sugar donor in the nucleus, we developed an
enzymatic assay for measurement of UDP-GalNAc substrate,
in which the standard curve showed an appropriate linear con-
centration range (Fig. S1A). High specificity of this enzymatic
method for UDP-GalNAc was demonstrated by comparison
with UDP-GlcNAc, which was found not to participate in the
reaction. UDP-GalNAc level was nextmeasured in various sub-
cellular fractions ofHeLa cells (Table 1). UDP-GalNAc concen-
trationwas very different in the nucleoplasm (0.330M) than in
the last nuclear wash (0.015 M), confirming the presence of
this sugar nucleotide in the nucleus.
To examine transport of UDP-GalNAc through the nuclear
membrane, we addedUDP-GalNAc to purified nuclei andmea-
sured the amount that passed inside. A substantial concentra-
tion (0.510M) of UDP-GalNAcwas found in the nucleoplasm,
reflecting the ability of this sugar nucleotide to enter the
nucleus (Table 1).
ppGalNAc-T activity in the nucleus
To evaluate ppGalNAc-T activity in the nucleus, terminal
glycans (products of each enzymatic reaction) were detected
using various labeled lectins as probes, and specificities of bioti-
nylated lectins were confirmed (Fig. S1, B–D).Vicia villosa lec-
tin (VVL) and Helix pomatia agglutinin (HPA) recognized ter-
minal GalNAc residues but not GlcNAc residues, whereas
wheat germ agglutinin (WGA) primarily recognized terminal
GlcNAc residues.We assayed ppGalNAc-T activity in subcel-
lular fractions of HeLa (human cervix), MCF7 (human breast),
T47D (human mammary gland), HEK-293 (human kidney),
Vero (monkey kidney) cell lines, and humanmononuclear cells
Figure 1. Purification of HeLa cell nuclei. A, whole cells (WC) and purified
nuclei (Nuc) were analyzed by confocal fluorescence microscopy to assess
nuclear purity following subcellular fractionation. Nuclei, Golgi, and ER
were identified, respectively, by staining with PI (red), anti-Golgin 97 anti-
body (green), and anti-calreticulin (CR) antibody. B,whole cells, cytoplasm
(Cyt), nuclei, and nucleoplasm (NP) samples were analyzed by WB, using
anti-Golgin 97 (Golgi), anti-CR (ER), and anti-tubulin (cytosol) antibodies
as cytoplasm markers, and anti-histone H3 (H3) antibody as nuclear
marker.
Nucleus synthesizes O-GalNAc glycans
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(HMC) using naked MUC1 and MUC2 as acceptor substrates
and excessive UDP-GalNAc as donor substrate. The enzymatic
product, GalNAc residues, was evaluated using the VVL
probe, and ppGalNAc-T activity was determined by extrapola-
tion from the standard curve of purified MUC1GalNAc (Fig.
S1C). ppGalNAc-T activity was detected in the cytoplasm
and nucleoplasm of analyzed cells (Table 2), whereas cata-
lytic activity was not observed in the last nuclear wash frac-
tion. Important ppGalNAc-T activity was detected in all
analyzed nucleoplasms, reflecting the enzyme’s capacity for O-
GalNAc glycosylation of nakedmucins.
ppGalNAc-T activity was next evaluated in the intact nuclei
of HeLa cells. Purified nuclei were incubated with added UDP-
GalNAc for 1 h at 37 °C, and the yielded glycans were detected
by WB and confocal microscopy using labeled lectins.
Increased numbers of terminal -linked GalNAc residues in
multiple nuclear proteins were demonstrated byWBwithHPA
(Fig. 2A). Terminal -linkage of GalNAc to proteins was dem-
onstrated using-N-acetylgalactosaminidase (GalNAc glyco-
sidase). Purified nuclei previously incubated with UDP-GalNAc
(OG nuclei) were washed, sonicated for nuclear membrane dis-
ruption, and incubatedwithoutorwithGalNAcglycosidase.The
number of GalNAc residues in glycosylated nuclear proteins was
greatly reduced in the presence of GalNAc glycosidase, indicat-
ing that terminal GalNAc was -anomeric. The findings that
intact nuclei display GalNAc-T activity to glycosylate
nuclear proteins and that this process is reversed by
GalNAc glycosidase indicate the capacity of nuclei for
GalNAc glycoprotein biosynthesis.
A comparison of the effects of UDP-GalNAc and UDP-GlcNAc
preincubation on glycosylation capacity of intact nuclei is
shown in Fig. 2B. Labeled VVL recognized an increased level of
terminal O-GalNAc glycans when purified nuclei were added
with UDP-GalNAc, whereas UDP-GlcNAc addition was not
recognized by VVL. When nuclei were added with UDP-Gal-
NAc,WB analysis with detection byWGAdid not recognize an
increase inO-glycosylation level. These findings indicate a clear
distinction between initiation of O-GalNAc versus O-GlcNAc
glycosylation of proteins in purified nuclei.
We examinedO-GalNAc glycosylation inside the nucleus by
confocal microscopy of purified intact nuclei of HeLa cells.
Constitutive O-GalNAc residues in these nuclei are shown
using VVL (Fig. 3A), as well as HPA and anti-Tn antibody (Fig.
S2) (top). The interaction of VVL with constitutive O-GalNAc
residues of intact nuclei was inhibited in the presence of
GalNAc (Fig. S3). Incubation of nuclei with added UDP-Gal-
NAc enhanced the product ofO-GalNAc glycosylation (Fig. 3A
and Fig. S2, bottom). Z-stacks of purified nuclei showed that in
Table 1
Measurement of UDP-GalNAc donor substrate in HeLa subcellular
fractions
Subcellular fraction UDP-GalNAc
M
Cytoplasm 24 2.7
Final nuclear wash 0.015 0.005
Nucleoplasm 0.330 0.052
Final nuclear wash (nuclei UDP-GalNAc) 0.060 0.009
Nucleoplasm (nuclei UDP-GalNAc) 0.510 0.091
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both situations (constitutive glycosylation and GalNAc over-
glycosylation),O-GalNAc residues were present in the nucleus,
indicating the occurrence of O-GalNAc glycosylation within
the nucleus. We next used fluorescence confocal imaging to
quantify levels of O-GalNAc residues following O-GalNAc
over-glycosylationofpurifiednuclei.Representativeimagesofmea-
surednuclei andOGnuclei, stainedwithVVLandPI, are shown in
Fig. 3B. Levels of terminal GalNAc residues per nucleus were
evaluated. Over-glycosylated O-GalNAc resulted in a 4.7-fold
(638.9/135.4) increase of O-GalNAc residues in purified nuclei
(Fig. 3C), indicating that nuclear GalNAc-T activity produced a
significant increase ofO-GalNAc glycosylation.
Finally, we studied ppGalNAc-T nuclear activity in intact
CHO ldlD cells. This cell line lacks a functional UDP-Gal-4-
epimerase and therefore relies on GalNAc salvaged from the
medium for the synthesis of UDP-GalNAc. CHO ldlD cells
were grown in media supplemented without (GalNAc) or
with (GalNAc) GalNAc, and the yielded glycans were
detected by confocal microscopy using labeled lectins (Fig. 4).
Incubation of cells with GalNAc in growing media enhanced
the product ofO-GalNAc glycosylation (Fig. 4A), resulting in a
5.8-fold increase in nuclear signal inGalNAc CHO ldlD cells
(Fig. 4B). The subcellular distribution of terminal GalNAc in
the cells reveals that a high portion of the signal coincides with
the nuclear marker DAPI (Fig. 4C), indicating nuclear ppGal-
NAc-T activity in intact cells.
Nuclear localization of ppGalNAc-T3
GalNAc-Ts are localized mainly in the Golgi; however, a few
ppGalNAc-T isoforms have been reported in other locations,
e.g. ER (17). We examined subcellular localization of isoforms
ppGalNAc-T2 (T2) and ppGalNAc-T3 (T3), with emphasis on
T3. Fluorescence microscopy assays with anti-human T2 and
T3 antibodies was performed to study subcellular localization
of these isoforms in HeLa, MCF-7, T47D, SK-N-AS, HEK-293,
MRC-5, Vero, and HMC cells (Fig. S4). T2 showed a character-
istic Golgi staining pattern in these cells (Fig. S4A). T3 showed
a nuclear staining pattern (overlap with nuclear marker DAPI)
in HeLa, MCF7, SK-N-AS, HEK-293, MRC-5, Vero, and HMC,
but not T47D. Distribution of T3 coincided mainly with the
nuclei, whereas T2 showed a Golgi distribution. Evidence for
the specificity of anti-T3 antibody was provided by WB and
competitive immunofluorescence assay using purified soluble
T3. Recombinant human soluble T3 was expressed in insect
cells and purified by affinity chromatography. We demon-
strated the purity of T3 by SDS-PAGEwith Coomassie Brilliant
Blue (CBB) staining, which revealed a protein of appropriate
molecular mass (72 kDa) (Fig. S4B). Anti-T3 antibody, onWB,
recognized a protein with corresponding molecular weight.
This antibody also recognized a unique protein with molecular
weight corresponding to that of T3 inHeLa cell homogenate. In
competitive immunofluorescence assay, recognition of T3 by
the antibody in HeLa cells was inhibited by the presence of
purified soluble T3 (Fig. S4C). The presence of soluble T3
strongly reduced both the dot-shaped nuclear pattern and the
Golgi staining pattern ofT3, indicating the ability of antibody to
specifically recognize endogenous T3 in HeLa cells.
T3 nuclear distributionwas analyzed by confocalmicroscopy
in purified nuclei, compared with whole HeLa cells (Fig. 5).
Delimitation of the nucleus was detected by staining of nucleic
acids with PI, and T3 was detected with anti-T3 antibody. Puri-
fication of nuclei removed T3 localized in Golgi but conserved
nuclear T3, as observed in many purified nuclei (Fig. 5A). Co-
localization of T3 with PI was observed in zoomed regions of
whole-cell nuclei and purified nuclei. Orthogonal views (x, y
and x, z views) of nuclear Z-stacks reveal co-localization of T3
with PI through the Z planes (Fig. 5B), confirming localization
of T3 inside the nucleus of HeLa cells.
Identification of O-GalNAc–glycosylated nuclear proteins
Proteins with O-GalNAc glycans were identified using a
combination of affinity chromatography of immobilized VVL
to select O-GalNAc glycoproteins and MS for protein identifi-
Figure 2. -Linked GalNAc glycosylation of nuclear proteins in HeLa
cells. A, purified nuclei (Nuc), over-glycosylated nuclei obtained by preincu-
bation of purified nuclei with 250 M UDP-GalNAc (OG Nuc), and OG nuclei
treated with GalNAc glycosidase (OG Nuc glycosidase) were analyzed by
SDS-PAGE (15% acrylamide) using biotin–HPA for O-GalNAc residue detec-
tion on proteins by WB. OG nuclei incubated without GalNAc glycosidase
showed identical O-GalNAc profile to UDP-GalNAc line (data not shown).
Loading controls (right): identical running gels stained with CBB. B, purified
nuclei (Nuc), over-glycosylated nuclei obtained by incubation of purified
nuclei with 250 M UDP-GalNAc (Nuc  UDP-GalNAc), and purified nuclei
incubated with 250 M UDP-GlcNAc (Nuc  UDP-GlcNAc) were analyzed by
SDS-PAGE (4–20% acrylamide gradient) and detected with biotin–VVL for
O-GalNAc glycan detection (left) or with biotin–WGA for O-GlcNAc glycan
detection by WB (middle). Loading controls as in A.
Nucleus synthesizes O-GalNAc glycans
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cation. Nucleoplasm from purified nuclei (constitutive
O-GalNAc glycosylated nuclear proteins) and nucleoplasm
from OG nuclei of HeLa cells were analyzed. Each nucleo-
plasm was divided into two equal parts: one part was loaded
onto streptavidin–agarose column (VVL column) to iden-
tify unspecific adsorption, and the other part was loaded onto
VVL-biotin/streptavidin–agarose column (VVL column) to
retain O-GalNAc–glycosylated proteins. Differences of
retained proteins between theVVL andVVL column were
evaluated by SDS-PAGE with colloidal CBB staining (Fig. S5).
Proteins from gel bands were digested, and peptides were iden-
tified by MS. The criterion for the presence of O-GalNAc gly-
cans on proteins was the identification of2 high-quality pep-
tides per protein, and peptide spectrum matches (PSM) ratio
3 (see “Experimental procedures”). Identified O-GalNAc–
glycosylated proteins in order of decreasing PSM ratio, their
subcellular localization, and main protein function according
to UniProt (http://www.uniprot.org),4 are listed in Table 3.
Two proteins were identified as endogenously O-GalNAc–
glycosylated in the nucleoplasm: 40S ribosomal protein S6
(RPS6) and S3 (RPS3) (Table 3A). They are both localized in
nuclei, according to UniProt. Twenty five glycoproteins were
detected in OG nucleoplasm, indicating the predominance of
nuclear localization in this group (Table 3B). PSM ratios of
RPS6 and RPS3 were 4 and 3, respectively; in contrast, some
proteins in the OG nucleoplasm group had much higher PSM
ratios (30 in the case of prelamin-A/C). These findings suggest
a direct correlation between O-GalNAc over-glycosylation,
major glycoprotein retention byVVL column, and increased
PSM ratio of proteins in the nucleoplasm. Incubation of puri-
fied intact nuclei with UDP-GalNAc led to detection of OG
proteins localized predominantly in the nucleus, indicating that
O-GalNAc glycosylation occurs inside the nucleus. The identi-
fied nuclear proteins with the highest O-GalNAc glycosylation
levels were prelamin-A/C (PSM ratio  30) and lamin B1
(LMNB1) (PSM ratio  22). We therefore examined nuclear
O-GalNAc glycosylation of lamins in more detail.
O-GalNAc glycosylation of LMNB1
Software programs are available with accepted algorithms
that allow theoretical predictions regarding O-GalNAc glyco-
sylation sites on proteins. Prediction of O-GalNAc glycosyla-
tion on LMNB1 was made using the NetOGlyc 4.0 Server
(www.cbs.dtu.dk/services/NetOGlyc/)4 (18). LMNB1 had a
large number of sites with a high likelihood of O-GalNAc gly-
cosylation (Table S1), consistent with our identification of
4 Please note that the JBC is not responsible for the long-term archiving and
maintenance of this site or any other third party hosted site.
Figure 3. Biosynthesis ofO-GalNAc glycans in HeLa cell nucleus. A, representative images from confocal fluorescence microscopy of purified nuclei (Nuc,
top) and OG nuclei incubated with UDP-GalNAc (OG Nuc, bottom). O-GalNAc residues on proteins were detected with Alexa 488–streptavidin/biotin–VVL
(green), and nuclei were stained with PI (red). Images of the nuclear plane are shown as individual channels andmergemode. Square, zoomed nuclear region,
also shown in x, y and x, z orthogonal views, show detailed distribution ofO-GalNAc glycans in the nucleus. Scale bar, 1m. B, representative confocal images
(inverted gray pseudocolored) showing O-GalNAc glycosylation level (detected with Alexa 488–streptavidin/biotin–VVL) (top) in purified nuclei (Nuc) and
purifiedOGnuclei (OGNuc).Controls:Alexa 488–streptavidinwithout biotin–VVL. Nuclei were stainedwith PI (bottom). Scale bar, 1m.C,quantitative analysis
ofO-GalNAcglycosylation level under conditions as inB. Fluorescenceof channel 1 (Alexa488) (AU, arbitraryunits) pernucleuswasmeasured in60nuclei. Lines,
mean arbitrary units. Means compared by unpaired t test indicate significant difference; *** (p 0.001). See also Fig. S2.
Nucleus synthesizes O-GalNAc glycans
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LMNB1 as a highly O-GalNAc–glycosylated protein following
incubation of purified nuclei with UDP-GalNAc.
O-GalNAc glycosylation of LMNB1 was evaluated by co-lo-
calization and FRET assays using fluorescence confocalmicros-
copy. Labeled Cherry–LMNB1 was overexpressed in HeLa
cells. Purified nuclei from these cells were incubatedwithout or
with UDP-GalNAc, and the resulting O-GalNAc glycosylation
was studied using biotin–VVL and Alexa 488–streptavidin.
Correlation analysis between VVL (channel 1) and LMNB1
(channel 2) was performed for control nuclei and OG nuclei
(Fig. 6A). Correlation of signals was stronger in the OG nuclei,
as a consequence of nuclear GalNAc-T activity. Fluorescence
profiles of the two channels were analyzed and showed greater
accompaniment of fluorescent intensities in the OG nuclei.
Comparison of fluorograms showed enhanced correlation
between LMNB1 andO-GalNAc residues following incubation
with UDP-GalNAc. The correlation was quantified by Pear-
son’s correlation coefficient for nuclei without or with UDP-
GalNAc preincubation and glycosylation detected with biotin–
VVL (GalNAc) or biotin–WGA (GlcNAc) (Fig. 6, B and C).
The correlation coefficient between LMNB1 and O-GalNAc
residues showed a 4.1-fold (0.630/0.151) increase after UDP-
GalNAc incubation and biotin–VVL detection, but no signifi-
cant change after biotin–WGA detection. These findings sug-
gest that LMNB1 is O-GalNAc–glycosylated in the nucleus.
O-GalNAc glycosylation of LMNB1was further evaluated by
acceptor photobleaching/FRET. Again, purified nuclei from
Cherry–LMNB1-overexpressing cells were incubated without
or with UDP-GalNAc to study LMNB1 O-GalNAc glycosyla-
tion, and biotin–VVL or biotin–WGA with Alexa 488–
streptavidin were used for O-glycan detection. FRET index for
each experimental condition was calculated as described under
“Experimental procedures.” A map of FRET index was pre-
pared, corresponding to representative images of nuclei prein-
cubated without or with UDP-GalNAc and detected with
biotin–VVL (Fig. 7A) or biotin–WGA (Fig. 7B). FRET index
was significantly higher for OG nuclei with O-GalNAc termini
of LMNB1 detected with biotin–VVL (Fig. 7C). Detection with
biotin–WGA gave no notable difference for control nuclei ver-
susOGnuclei (Fig. 7,B andD). The increase in FRET indexwith
biotin–VVL detection confirms that O-GalNAc residues are
added to LMNB1 in the nucleus, showing the ability of nuclei to
synthesize O-GalNAc glycans.
Discussion
PTMs are essential modulators of cell homeostasis, play key
roles in protein function and localization, and regulate cell
Figure 4. Nuclear O-GalNAc glycosylation in CHO ldlD cells. A, represen-
tative images fromconfocal fluorescencemicroscopyof CHO ldlD cells grown
in media without GalNAc (GalNAc; top) or supplemented with GalNAc
(GalNAc; bottom).O-GalNAc residues on proteins were detectedwith Alexa
488–streptavidin/biotin–VVL (green) and nuclei stained with DAPI (blue).
Images are shown as individual channels andmergemode. Scale bar, 10 m.
B, quantitative analysis of nuclear O-GalNAc glycosylation level under condi-
tions as in A. Mean fluorescence in nuclear region per cell was measured in
GalNAc orGalNAcgrowing conditions. Values are expressed as relative to
the lower average fluorescence value. Lines, mean S.D. (n 56–60 cells).
Means compared by unpaired t test indicate significant difference; *** (p 
0.001). C, confocal Z-stack images of a representative CHO ldlD cell grown in
media with GalNAc. Axial views (x, z) (bottom panel) along the yellow line
displayed in the upper panel allows us to appreciate the distribution ofO-Gal-
NAc terminals (green) outside and inside of the nucleus (blue). Images are
shown as individual channels andmergemode. Scale bar, 1 m.
Figure 5. Localizationof ppGalNAc-T3 (T3) in thenucleus ofHeLa cells.A,
representative images from confocal fluorescencemicroscopy of whole cells
(WC; top) and purified nuclei (Nuc; bottom) showing T3 stained with anti-T3
antibody (green) and nuclei stained with PI (red). Scale bar, 10 m. B, maxi-
mum intensity projection and corresponding axial views (x, z) of confocal
Z-stack images of whole cells and purified nucleus with notations as in A.
Images are shown as individual channels and merge mode. Scale bar, 1 m.
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interactions in a variety of biological processes. Many nuclear
proteinsundergoPTMs(notablyacetylation,methylation,phos-
phorylation, ubiquitination, and glycosylation in mammalian
cells) that affect gene expression and nuclear physiology (7, 19,
20). We studied biosynthesis of O-GalNAc glycans in the
nucleus of human cells and documented the presence of all
factors necessary for initiation ofO-GalNAc protein glycosyla-
tion: the sugar donor substrate, catalytic ppGalNAc-T activity,
an enzyme (polypeptide GalNAc-T3), and products of the
enzymatic reaction.
O-GalNAc glycosylation of proteins is initiated by
ppGalNAc-Ts catalyzing covalent linkage of GalNAc to the
hydroxyl residue of Ser or Thr. This enzymatic reaction
requires two substrates: a sugar donor (UDP-GalNAc) and a
protein acceptor substrate. Mucin-type domains are more
frequentlyO-GalNAc–glycosylated in amino acid sequences
having predominant presence of Ser and Thr, surrounding
Pro. Proteins with mucin-type domains are widely distrib-
uted in cells, including the nucleus. We developed a highly
specific and sensitive quantification method to detect UDP-
GalNAc substrate in nuclei, and we used it to measure a
0.330 M concentration of UDP-GalNAc in HeLa cell nucleo-
plasm. Hart and Akimoto (21) reported a similar concentration
(0.50 M) of UDP-GlcNAc in the nucleoplasm, whereas Bond
and Hanover (22) described UDP-GlcNAc concentrations
ranging from 2 to 30 M in the cytoplasm, nuclei, and mito-
chondria. As in glycosylation reactions, two substrates are
required, and the relevance of this UDP-GalNAc concentration
in the nucleus is conditioned by enzyme’s Km value of donor
substrate, which is depending on the nuclear amino acid
sequence of the acceptor substrate. When we incubated puri-
fied intact nuclei with added UDP-GalNAc, we observed a sub-
stantial concentration (0.510M) ofUDP-GalNAc in the nucle-
oplasm. These findings reflect the ability of UDP-GalNAc to
reach the nucleoplasm by crossing the nuclear membrane.
UDP-GalNAc synthesized in cytoplasm is thus able to cross the
nuclear membrane and be available as a sugar donor substrate
for nuclear ppGalNAc-Ts. Bond and Hanover (22) described
similar nuclear membrane permeability and the ability of
UDP-GlcNAc to enter the nucleus. Concentrations of UDP-
GalNAc and its epimer UDP-GlcNAc are directly affected by
nutrient availability. Similarly to previous findings for
UDP-GlcNAc concentration, metabolic alterations that affect
the UDP-GalNAc concentration may alter nuclear ppGalNAc-T
activity and thereby regulate levels ofO-GalNAc glycosylation on
nuclear proteins.
We demonstrated significant ppGalNAc-T activity in all
nucleoplasms of several cells, reflected by the catalytic capacity
to link GalNAc to naked MUC1 and MUC2 (Table 2). HMC
nucleoplasm showed ppGalNAc-T activity with MUC2 accep-
Figure 6. Correlation study of LMNB1 and O-GalNAc glycosylation in HeLa cells. A, purified nuclei (Nuc) preincubated without or with UDP-GalNAc (OG
Nuc) of cells expressing Cherry–LMNB1 (red) were fixed and stained with VVL for detection of O-GalNAc residues (green) and correlation analysis of O-GalNAc
glycosylation (1st channel) and LMNB1 (2nd channel). Top panels, representative confocal fluorescence images of nuclei and OG nuclei as separated channels
andmergemode. Yellow color, overlap of signals. Scale bar, 10 m.Middle panel, fluorescence profiles of the two channels along the white line shown in the
merge images. Stronger correlation is seen for OG nuclei between O-GalNAc glycosylation (green line) and LMNB1 (red line). Bottom panel, corresponding
fluorograms between 1st and 2nd channels for nuclei and OG nuclei. B, quantification of Pearson’s correlation coefficient between O-GalNAc glycosylation
(detected with VVL) and Cherry–LMNB1 in nuclei and OG nuclei. C, quantification of Pearson’s correlation coefficient betweenWGA (which detectsO-GlcNAc
termini; control) and LMNB1 in nuclei andOGnuclei. Data shown aremean Pearson’s correlation coefficient S.E. (n 5). Means compared byMann-Whitney
test indicate significant difference; * (p 0.05) or ns (not significant).
Nucleus synthesizes O-GalNAc glycans
3004 J. Biol. Chem. (2019) 294(9) 2997–3011
 at U
niversity at Buffalo Libraries on M
arch 8, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
tor, but it was not observed on the MUC1 acceptor. It could be
explained because this enzyme activity is conditioned by the
ppGalNAc-T isoforms present in the nucleoplasm of each cel-
lular type. The fact that ppGalNAc-T activity is present in non-
tumoral (HEK-293, Vero, and HMC) and tumoral (HeLa,
T47D, and MCF-7) nucleoplasms, as well as in nuclei of CHO
ldlD cells suggests that the presence ofO-GalNAc glycosylation
machinery in the nucleus would be a normal physiological pro-
cess. ppGalNAc-T activity was also observed in HeLa purified
nuclei, and incubation of purified nuclei with added donor sub-
strate (UDP-GalNAc) enhanced theO-GalNAc glycosylation of
several proteins. Studies of -anomeric GalNAc linkage to
nuclear proteins, and linkages of various controls (including
UDP-GlcNAc and WGA), showed that the N-acetylhexo-
samine linkage in this case is not GlcNAc, as described previ-
ously for other nuclear proteins. Following preincubation of
purified nuclei with UDP-GalNAc, confocal microscopy assays
revealed O-GalNAc glycosylation inside the nucleus. Another
key point in this studywas the demonstration of nuclear ppGal-
NAc-T activity in intact cells. CHO ldlD cells are a robust
model for studying the initiation of O-GalNAc glycosylation
given that they are deficient in UDP-Gal and UDP-GalNAc
4-epimerase and are therefore unable to synthesizeUDP-Gal or
UDP-GalNAc. The addition of GalNAc to CHO ldlD cell cul-
ture medium allowed us to demonstrate that the incorporation
of O-GalNAc terminals is also occurring in the nuclei of intact
cells.
Localization in nuclei of ppGalNAc-T3 (T3), an enzyme that
initiates O-GalNAc glycan biosynthesis, was observed by
microscopy in different whole cells and purified nuclei. Glyco-
syltransferases are generally localized in Golgi of mammalian
cells (11), but other subcellular localizations have been
reported, e.g. sialyltransferase in plasma membrane (23),
O-GlcNAc-transferase in mitochondria, cytoplasm, and nuclei
(24), and ppGalNAc-Ts in ER (17). We demonstrate here the
nuclear localization of T3 in different cells, similarly reported
by Human Protein Atlas in human RT4 cell nuclei (https://www.
proteinatlas.org/ENSG00000115339-GALNT3/cell#img (26)).4
TheppGalNAc-Tactivity observed inT47D nucleoplasm, with-
out T3 nuclear localization, is consistent with the presence
of additional ppGalNAc-T isoforms in the nucleus. The
Human Protein Atlas (www.proteinatlas.org (26))4 reports
the presence of six isoforms of the ppGalNAc-T family
(ppGalNAc-T5, -T6, -T7, -T10, -T14, and -T16) in the nuclei
of various human cell lines (25, 26).
Identification of O-GalNAc–glycosylated nuclear proteins
indicated the occurrence of a PTM not previously described in
the nuclei and suggested that O-GalNAc glycosylation may
modulate functions of certain nuclear proteins. Accordingly,
we studied constitutive and over-glycosylated O-GalNAc
nuclear proteins.O-GalNAc–glycosylated proteins from HeLa
nucleoplasm were purified on an affinity chromatography col-
umn using immobilized VVL, and retained glycoproteins were
identified by MS. Two proteins (RPS6 and RPS3), both known
Figure7.O-GalNAcglycosylationof lamin-B1 (LMNB1) innuclei ofHeLa cells.A andB,nuclearO-GalNAcglycosylationof LMNB1was analyzedby acceptor
photobleaching FRET in purified nuclei expressing Cherry–LMNB1, preincubated without (Nuc) or with UDP-GalNAc (OG Nuc). O-Glycosylation was detected
with Alexa 488–streptavidin/biotin–VVL (GalNAc residues) or Alexa 488–streptavidin/biotin–WGA (GlcNAc residues, control). A, representative images of
VVL (O-GalNAc glycosylation) and LMNB1 (top) orWGA (control) and LMNB1 (bottom) FRET indexmap in purified nuclei andOGnuclei. Color-code bar indicates
FRET index (0 to 1) for each pixel. For OG nuclei, FRET is between VVL and LMNB1, indicating that LMNB1 isO-GalNAc–glycosylated in the nucleus. Scale bar, 1
m. C and D, statistical analysis of FRET index of LMNB1 and VVL (O-GalNAc terminals) (C), and LMNB1 and WGA (D), in purified nuclei preincubated without
(Nuc) or with UDP-GalNAc (OG Nuc). Data shown are mean FRET index S.E. (n 5). Means compared by Mann-Whitney test indicate significant difference;
** (p 0.01) or ns (not significant).
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to be localized in nucleus and cytoplasm, were identified as
constitutively O-GalNAc–glycosylated. It is likely that numer-
ous other nuclear proteins are constitutively O-GalNAc–
glycosylated but were not retained on the VVL column because
this lectin recognizes glycoproteins with terminal GalNAc res-
idues. Constitutive O-GalNAc glycosylation could thus con-
tinue the glycan biosynthetic pathway with capping of the ini-
tial GalNAc residue and evade VVL recognition.
Incubation of purified nuclei with UDP-GalNAc allowed
identification of numerous O-GalNAc–glycosylated proteins.
Of 25 such proteins (Table 3B), 22 are localized in the nucleus.
This finding confirms that biosynthesis of O-GalNAc glycans
occurs in the nucleus, because the approach involves incuba-
tion of purified nuclei with UDP-GalNAc. Among the 22 pro-
teins as above, PSM ratios were highest for pre-LMNA/C and
LMNB1. These two proteins, and LMNB2, are essential com-
ponents of the nuclear lamina, a filamentous layer located
between the inner nuclear membrane and peripheral hetero-
chromatin that plays crucial roles in nuclear organization and
interactions with the genome, including promoter regions that
modulate gene expression (27, 28). Other nuclear proteins
identified as O-GalNAc–glycosylated (Table 3B) include the
following: (i) splicing factor, proline- and glutamine-rich
(SFPQ) and non-POU domain-containing octamer-binding
protein (NONO), characteristic components of nuclear body
paraspeckles, which are involved in control of gene expression
during cellular processes such as differentiation, viral infection,
and stress responses (29); (ii) ribosomal proteins that are
involved in translation, DNA repair (RPS3), and mRNA catab-
olism (RPS18 and RPS3A) (30–32); (iii) RNA-binding motif
protein, X chromosome, and ATP-dependent RNA helicase A
(DHX9) involved in gene expression, transcriptional activation,
and RNA processing (33, 34). In view of the varied functions of
identified proteins as above, nuclear O-GalNAc glycosylation
may play essential roles in nuclear homeostasis.
Additional methods were applied for the study of LMNB1,
which had a high PSM ratio, and a prediction of highly probable
O-GalNAc glycosylation. Co-localization analysis ofO-GalNAc
residues and LMNB1 revealed an increase of Pearson’s correla-
tion coefficient as a consequence ofO-GalNAc over-glycosyla-
tion. Similarly, FRET index between O-GalNAc glycans and
LMNB1was increased byO-GalNAcover-glycosylation.Co-lo-
calization and FRET studies thus confirmed the nuclearO-Gal-
NAc glycosylation of LMNB1, in agreement with findings from
affinity chromatography andMS. Nuclear lamins play key roles
in nuclear organization, nuclear physiology, and gene expres-
sion (35, 36). They undergo extensive PTMs (e.g. phosphoryla-
tion and sumoylation) that help determine their localization
and dynamics (37, 38). Lamins can also be ADP-ribosylated or
N-glycosylated (7, 39). Wang et al. (40) reported that LMNA
was O-GlcNAc–glycosylated in HeLa cells. By using other
experimental approaches (SimpleCell strategy), Steentoft et al.
(18) reported the presence of O-GalNAc–glycosylated nuclear
proteins, and Yang et al. (41) has described O-GalNAc glyco-
sylation sites of Lamin-A/C, 40S ribosomal protein SA, and
elongation factor 1-1 (EF-1--1) nuclear proteins of CHO
cells, in agreement with our results. No previous study has pre-
sented experimental evidence of LMNB1 O-glycosylation.
LMNB1 plays crucial roles in high-order chromatin organiza-
tion, DNA replication, and transcriptional activity (42, 43).
In conclusion, this study provides solid evidence of O-
GalNAc glycan biosynthesis machinery in the nucleus of
human cells. All factors necessary for initiation of such biosyn-
thesis are present in the nucleus: the required donor substrate
(UDP-GalNAc); nuclear ppGalNAc-T activity; an enzyme (T3);
and the identified O-GalNAc–glycosylated proteins in the
nucleus. This is the first demonstration of O-GalNAc glycosyl-
ation of nuclear human proteins. Because UDP-GalNAc bio-
synthesis is sensitive to cellular Glc concentration, biosynthesis
ofO-GalNAc glycans in the nucleusmay be significantly altered
in situations involving changes in sugar metabolism, e.g. diabe-
tes. Increased levels ofO-GalNAc residues (e.g. Tn antigen) are
often observed in epithelial cancer cells and likely may reflect
changes in nuclearO-GalNAc glycan abundance. Diabetes and
epithelial cancer are both associated with widespread changes
in gene expression, which likely involve O-GalNAc glycans.
PTMs of nuclear proteins play key roles in many nuclear phys-
iological processes. It is therefore important to further eluci-
date the functions of O-GalNAc glycans in nuclear proteins.
This is the focus of our ongoing studies.
Experimental procedures
Cell lines
Human cervical cancer (HeLa), human breast adenocarci-
noma (MCF7), human breast tumor (T47D), humanneuroblas-
toma (SK-N-AS), human kidney (HEK-293), human lung
(MRC-5), monkey kidney (Vero) cell lines, Chinese hamster
ovary (CHO) mutant cell line ldlD, and insect Sf9 cells were
from CIQUIBIC-CONICET/Department of Biological Chem-
istry, Universidad Nacional de Co´rdoba, Argentina. Human,
hamster, and monkey cell lines were grown at 37 °C in an incu-
bator (10% CO2 atmosphere) in Dulbecco’s modified Eagle’s
medium (Sigma) supplementedwith 10% fetal calf serum, 1mM
sodium pyruvate, and nonessential amino acids. To study the
initiation of O-GalNAc glycosylation, CHO ldlD cells were
grown in complete media supplemented with 1.5 mM GalNAc
(GalNAc) or not GalNAc (GalNAc) during 48 h (44). Insect
cells were grown at 27 °C in Grace’s insect medium (Sigma)
containing 10% fetal calf serum. Human mononuclear cells
(HMC) were obtained from blood (from F. J. I.) by centrifuga-
tion at 400  g for 30 min at 25 °C with Histopaque-1077
(Sigma).
Nuclei and nucleoplasm purification
Nuclei andnucleoplasmwere purified as described by Shech-
ter et al. (15) with some modifications. In brief, cultured cells
were trypsinized, harvested, and washed with PBS by centrifu-
gation at 300 g for 10min at 4 °C. 1 107 cells were incubated
with 1 ml of extraction buffer (10 mM HEPES, pH 7.9, 10 mM
KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol) containing
0.2% Nonidet P-40 and protease inhibitors for 10 min on ice,
with occasional rotation for cell lysis. The sample was centri-
fuged at 6,500 g for 5 min at 4 °; the supernatant (cytoplasm)
was recovered, and the pellet (intact nuclei) was washed three
times with 1 ml of extraction buffer (without Nonidet P-40).
Purity of nuclei was evaluated by immunofluorescence confocal
Nucleus synthesizes O-GalNAc glycans
3006 J. Biol. Chem. (2019) 294(9) 2997–3011
 at U
niversity at Buffalo Libraries on M
arch 8, 2019
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
microscopy using mouse anti-Golgin 97 and mouse anti-calre-
ticulin antibody as membrane organelle markers and Alexa
488-labeled rabbit anti-mouse IgG antibody as secondary re-
agent. Nuclei were stained with PI.
To obtain soluble the nuclear fraction (nucleoplasm), puri-
fied nuclei as above were lysed by incubation with 400 l of
high-salt solubilization buffer (50 mM Tris-HCl, pH 8.0, 2.5 M
NaCl, 0.05% Nonidet P-40) for 20 min at 4 °C and then soni-
cated. The sample was centrifuged at 16,000  g for 10 min at
4 °C, and supernatant (nucleoplasm) was recovered. A portion
of each fraction equivalent to 1.5  105 cells was subjected to
4–20% SDS-PAGE. Purity of nuclei and nucleoplasm was eval-
uated by Western blotting with organelle molecular markers.
Samples were also analyzed by CBB staining as loading control.
Fluorescencemicroscopy
Cells were grown on glass coverslips, and purified nuclei
were seeded on polylysine-coated coverslips. Purified nuclei
and cells were fixed for 20min in 2%paraformaldehyde in phos-
phate-buffered saline (PBS: 20 mM sodium phosphate, pH 7.4,
150 mM sodium chloride), washed with PBS, permeabilized
with 0.1% Triton X-100 and 200 mM glycine in PBS for 2 min,
andwashed againwith PBS. Samples were blocked in 3% bovine
serum albumin (BSA) for 60min at room temperature and then
incubated with antibody or lectin in PBS, 1% BSA for 2 h at
room temperature. Antibodies used were as follows: mouse
anti-Golgin 97 (1:500; A-21270; ThermoFisher Scientific);
mouse anti-calreticulin (1:1,000; 612137; BD Biosciences); rab-
bit anti-human ppGalNAc-T3 (1:500; HPA007613; Sigma); and
rabbit anti-human ppGalNAc-T2 (1:500; HPA011222; Sigma).
Samples were washed with PBS and stained with Alexa 488- or
546-conjugated anti-rabbit or anti-mouse IgG (1:1,000; Invitro-
gen) for 1 h at room temperature.
For glycan detection, fixed, permeabilized, and blocked cells
or nuclei were incubated with biotinylated lectins: H. pomatia
agglutinin (biotin–HPA; 1:1,000; L6512; Sigma); V. villosa lec-
tin (biotin–VVL; 1:2,500; B-1235; Vector Laboratories); or
wheat germ agglutinin (biotin–WGA; 1:500; B-1025, Vector
Laboratories) for 2 h at room temperature. Monoclonal IgM
anti-Tn antibody (5F4) was incubated overnight at 4 °C,
washed, and then incubated with biotinylated goat anti-mouse
IgM antibody (1:1,000, BA-2020, Vector Laboratories) in PBS,
1% BSA for 2 h at room temperature. Samples were washed and
stained for 1 h at room temperature with Alexa 488–streptavidin
(1:2,000; 532354; Life Technologies, Inc.). Controls for immuno-
staining specificitywere includedwithAlexa-conjugated anti-rab-
bit or -mouse IgG antibody or Alexa–streptavidin, but without
primary antibody or biotinylated lectin. Nuclei were stained with
DAPI and PI. Samples were mounted onto glass slides using Flu-
orSave (Calbiochem). Images of ppGalNAc-T2 (T2) and ppGal-
NAc-T3 (T3) in the four human cell lines were obtained with a
fluorescence microscope (Carl Zeiss, Axioplan) using PlanApoN
601.42NAoil immersionobjective. Images showing subcellular
distribution of T3 and O-GalNAc glycosylation were obtained
with a confocalmicroscope (model FV-1000,Olympus) using Pla-
nApoN objective. Confocal images were acquired in sequential
mode to avoid bleed-through between channels. Images were
obtained in x, y and x, y, z scanmodes. For zoomed images, region
mode clip was performed, and stacks of equidistant (0.10 or 0.17
m) planes were acquired. Zoom was adjusted to achieve 0.045
m per pixel. Images were processed using the Fiji software pro-
gram (45).
Western blotting (WB)
Protein samples were analyzed by SDS-PAGE as described
previously (46). For protein antigens, electrotransferred mem-
branes were blocked with 5% skim milk in PBS for 60 min at
room temperature and incubated with appropriate primary
antibodies overnight at 4 °C. The antibodies used (see details
for some antibodies under “Fluorescence microscopy”) were
mouse anti--tubulin (1:2,500; clone DM1A, T9026; Sigma),
mouse anti-Golgin 97 (1:100), mouse anti-calreticulin, and rab-
bit anti-histone H3 (1:5,000; AS10 710; Agrisera). Membranes
were washed with PBS, incubated with IRDye 800-conjugated
goat anti-rabbit or goat anti-mouse IgG antibody (1:20,000; LI-
COR Biosciences) for 1 h at room temperature, washed again,
and analyzed with an Odyssey IR Imaging System (LI-COR).
For glycoprotein analysis, membranes were blocked with 3%
polyvinylpyrrolidone (PVP) in PBS for 60 min at room temper-
ature, incubated with biotin–HPA (1:1,000; Sigma), biotin–
VVL (1:2,000; Vector Laboratories), or biotin–WGA (1:500;
Vector Laboratories) for 2 h at room temperature, and then
washed and incubated with IR800 dye-labeled streptavidin
(1:30,000; LI-COR) in 0.3% PVP in PBS for 30 min at room
temperature. Glycoproteins transferred to membrane were
analyzed by IR imaging as above.
Expression and purification of recombinant human
ppGalNAc-Ts
Human soluble ppGalNAc-T2 (T2) and ppGalNAc-T3 (T3)
cDNAs were cloned into baculovirus expression vector
pAcGP67 as described previously (47). Secreted, soluble pro-
teinswere purified from supernatant of Sf9 cell culturemedium
following centrifugation at 2,000  g for 30 min at 4 °C. The
supernatant was dialyzed (membrane MWCO 10 kDa)
against PBS and centrifuged at 2,500  g for 30 min at 4 °C.
Proteins were purified using HisPurTM cobalt resin (Thermo-
Fisher Scientific), eluted with 150mM imidazole, dialyzed three
times against PBS, and concentrated by a centrifuge filter
device(MWCO10kDa;Millipore).Totalproteinsweremea-
sured by bicinchoninic acid assay with BSA as standard
(Pierce; ThermoFisher Scientific). Purity of recombinant
human ppGalNAc-Ts was assessed by 10% SDS-PAGE and
CBB staining.
UDP-GalNAcmeasurement
UDP-GalNAc was measured by enzymatic assay. Microtiter
plates were adsorbed with 2 g/ml MUC1 peptide in coating
buffer overnight at 4 °C, washed with PBS, and blocked with
PBS with 0.1% Tween 20 for 1 h at room temperature. Catalytic
reaction mixture containing 25 mM sodium cacodylate, pH 7.4,
10mMMnCl2, 0.05%Tween 20, and 10 nM purified T2 in a total
volume of 45 l was incubated with either 5 l of HeLa cyto-
plasm, last nuclear wash before obtaining nucleoplasm, or
nucleoplasm for 15 min at 37 °C. Additional multiwell plates
adsorbed with 2 g/ml MUC1 were incubated with catalytic
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reaction mixture and various concentrations of UDP-GalNAc
(Sigma) as standard, for construction of a reference curve. After
catalytic reactions, plates were washed with PBS, incubated
with biotin–VVL (1:1,000) in PBS with 0.05% Tween 20 for 60
min at room temperature, washed again with PBS, incubated
with HRP–streptavidin (1:2,500) in PBS with 0.05% Tween 20
for 30 min at room temperature, and washed again with PBS.
Peroxidase colorimetric reaction and absorbance reading were
as described above.
To evaluate the capacity of UDP-GalNAc to enter the
nucleus, 50 l of purified nuclei were incubated with 50 l of
UDP-GalNAc (500 M) in TBS for 10 min on ice, and washed
three times with 1 ml extraction of buffer (10 mM HEPES, pH
7.9, 10mMKCl, 1.5 mMMgCl2, 0.34 M sucrose, 10% glycerol) by
centrifugation at 6,500  g for 5 min at 4 °C. Purified nuclei
were sonicated, and the supernatant (nucleoplasm) was
obtained by centrifugation at 16,000  g for 10 min at 4 °C.
UDP-GalNAc was measured in samples corresponding to the
last nuclear wash and nucleoplasm.
Specificity of HPA, VVL, andWGA lectins
Lectin specificities were analyzed as described previously
(48). Polystyrene microtiter plates (Corning, Costar) were
coated with various concentrations of peptide MUC160
(TAPPAHGVTSAPDTRPAPGSTAPPAHGVTSAPDTRPA-
PGSTAPPAHGVTSAPDTRPAPGS) (MUC1), glycopeptide
MUC160GalNAc15 (MUC1GalNAc), BSA, or ovalbumin
in 0.1 sodium carbonate, pH 9.6, 0.5 M NaCl (coating buffer)
overnight at 4 °C, washed with PBS, and blocked with 0.1%
Tween 20 in PBS for 1 h at room temperature. Naked (MUC1
and BSA) and glycosylated proteins (MUC1GalNAc and
ovalbumin) were incubated with biotin–VVL (1:1,000),
biotin–HPA (1:1,000), or biotin–WGA (1:600) in PBS with
0.05% Tween 20 for 60 min at room temperature. Multiwell
plates were washed with PBS, incubated 30 min at room
temperature with HRP–streptavidin (1:2,500; DakoCytoma-
tion) in PBS with 0.05% Tween 20, and washed with PBS.
Colorimetric reaction was developed with 0.5 mg/ml o-phe-
nylenediamine and 0.02% H2O2 in 100 mM sodium citrate,
pH 5.0, for 15min at room temperature, and the reaction was
stopped by addition of 0.5 N H2SO4. Absorbance was read by
microplate reader at 490 nm.
ppGalNAc-T activity
Microtiter plates were adsorbed with 2 g/ml MUC124
(TAPPAHGVTSAPDTRPAPGSTAPP)orMUC233 (PTTTPITT-
TTTVTPTPTPTGTQTPTTTPISTTC) in coating buffer over-
night at 4 °C, washedwith PBS, and blockedwith PBSwith 0.1%
Tween 20 for 1 h at room temperature. Catalytic reaction mix-
ture (45 l) containing 25 mM sodium cacodylate, pH 7.4, 10
mM MnCl2, 0.05% Tween 20, and 100 M UDP-GalNAc was
incubated with either 5 l of cytoplasm, last nuclear wash, or
nucleoplasm for 15 min at 37 °C. The product, MUCGalNAc,
was detected with biotin–VVL as described above (49). Each
sample was analyzed in triplicate.
For construction of the standard curve, microtiter plates
were adsorbed with various concentrations of MUC1GalNAc
in coating buffer overnight at 4 °C, washed with PBS, and
blocked with PBS with 0.1% Tween 20 for 1 h at room temper-
ature. GalNAc residues were detected using biotin–VVL as
described in above. GalNAc-T activity was expressed as inter-
national units (1 unit  1 mol of -linked GalNAc/min) and
normalized relative to total proteins (units/mg).
O-GalNAc glycosylation in purified nuclei
Purified nuclei were divided into three equal samples and
incubated with equal volumes of TBS with either 10mMMnCl2
(endogenous glycosylation), TBS with 10 mM MnCl2 and 500
M UDP-GalNAc (O-GalNAc over–glycosylated nuclei; “OG
nuclei”), or TBS with 10 mMMnCl2, and 500 MUDP-GlcNAc
(control) for 1 h at 37 °C. Nuclei were then washed three times
with TBS, and the resulting purified nuclei were analyzed by
fluorescence microscopy and WB. For fluorescence micros-
copy studies, treated nuclei were seeded on polylysine-coated
coverslips, fixed, blocked, permeabilized, and incubated with
biotinylated lectins (HPA and VVL) or monoclonal IgM
anti-Tn antibody (5F4) to reveal GalNAc residues. Nuclei
were stained with PI and imaged by confocal microscopy
(model FV-1000,Olympus) in x, y and x, y, z scanmodes. Region
mode clipwas performed, and stacks of 20–30 equidistant (0.17
m) planes were acquired. Zoomwas adjusted to achieve 0.045
m per pixel. Images were acquired using identical settings of
laser power, detector gain, and offset.
HeLa cells, cytoplasm, purified nuclei, purified nuclei prein-
cubated with UDP-GalNAc (OG nuclei), and purified nuclei
preincubated with UDP-GlcNAc (control) were analyzed by
WB using biotin–VVL and biotin–WGA. A portion of each
fraction equivalent to 1.5  105 cells was subjected to 4–20%
SDS-PAGE and CBB-stained or electrotransferred to nitrocel-
lulose membranes. O-GalNAc and O-GlcNAc glycoproteins
were detected, respectively, with biotin–VVL and biotin–
WGA. PurifiedOGnuclei were sonicated, incubatedwithout or
with chicken liver -N-acetylgalactosaminidase (A9763;
Sigma) in 100 mM sodium citrate, pH 5.5, for 2 h at 37 °C, and
analyzed by SDS-PAGE (12% acrylamide) andWBwith biotin–
HPA detection.
Quantification of nuclear O-GalNAc glycosylation
Purified nuclei and OG nuclei were processed for fluores-
cence microscopy, stained with Alexa 488–streptavidin (nega-
tive control: without lectin) or with biotin–VVL followed by
Alexa 488–streptavidin, and finally stained with PI. Samples
were imaged in x, y, z scan mode, and stacks of 3–4 equidistant
(0.7 m) planes were obtained. Images were acquired with
identical settings of laser power, detector gain, and offset.
Z-stack images were processed by Fiji program. Signal in the
488 channel (corresponding to O-GalNAc glycosylation
detected with VVL and nonspecific signal in negative controls)
was measured. The z axis profile and selection of the nuclear
plane (546 channel) (PI) were performed for each stack. A
nuclearmask created by nuclear signal thresholding (546 chan-
nel) (Huang method) was used to determine mean intensity in
the 488 channel for each nucleus, under each condition. Back-
ground was pre-subtracted for both channels.
CHO ldlD cells grown in coverslips were processed for fluo-
rescence microscopy in the same way that purified nuclei, and
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the cell nucleus was stained with DAPI. Images of cells were
acquired with identical settings andwere processed in the same
way using Fiji software. To measure the signal in the nuclear
region, nuclear masks were generated by DAPI nuclear signal
thresholding. Background was subtracted, and the mean fluo-
rescence in the nuclear region corresponding to nuclear termi-
nalO-GalNAc wasmeasured in 58–60 individual cells for each
condition (GalNAc/GalNAc). The resulting fluorescence
values were relativized to the average fluorescence in the
GalNAc condition (the condition with lower O-GalNAc gly-
cosylation), and finally, measurements were expressed as rela-
tive nuclear mean fluorescence. All data were analyzed using
the GraphPad Prism 5 software program.
Specificity of rabbit anti-human T3 antibody
Purified human T3 (1 g) or HeLa homogenate (40 g) was
loaded onto 10% SDS-PAGE, electrotransferred, and analyzed
by WB using rabbit anti-human T3 antibody and IRDye 800-
conjugated goat anti-rabbit IgG antibody (1:20,000). Specificity
ofT3 (72 kDa) recognitionwas analyzed based on themolecular
weight of recognized protein.
Specificity of the anti-human T3 antibody was evaluated by
competitive immunofluorescence assay. HeLa cells were grown
on coverslips and subjected to immunofluorescence micros-
copy. Fixed, permeabilized, and blocked cells were incubated
for 2 h at room temperature with anti-human T3 antibody
(1:500) either alone (control) or with purified human T3 (0.9
g/ml). Coverslips were washed and incubated with Alexa 546-
conjugated anti-rabbit IgG antibody (1:1,000), and nuclei were
stained with DAPI. Samples were imaged as described under
“Fluorescence microscopy,” using identical settings of laser
power, detector gain, and offset.
Identification of O-GalNAc–glycosylated proteins
O-GalNAc glycoproteins from HeLa nucleoplasm (endoge-
nous glycosylation) and nucleoplasm from OG nuclei were
purified by affinity chromatography using VVL–biotin/
streptavidin–agarose column (VVL column).VVL column
was prepared by incubation of 100 g of biotin–VVL with
100 l of streptavidin–agarose CL-4B (85881; Sigma) for 1 h
at 4 °C, washed with 10 volumes TBS, and divided into two
50-l parts. To obtain nucleoplasm, 2  107 HeLa-purified
nuclei or OG nuclei (preincubated with UDP-GalNAc for 1 h
at 37 °C) were lysed in high-salt solubilization buffer as
described previously (15). Each nucleoplasm was pre-ad-
sorbed with 50 l of streptavidin–agarose column for 1 h at
4 °C. Resulting nucleoplasms were divided into two equal parts,
which were incubated, respectively, with 50 l of VVL-biotin/
streptavidin–agarose column (VVL column) and with 50 l
of streptavidin–agarose column without VVL (VVL column)
for 1 h at 4 °C. Columns were washed with 20 volumes of TBS,
resuspended in Laemmli sample buffer, and heated at 90 °C for
10 min. Samples were loaded onto SDS-PAGE (12% acrylam-
ide), run until 1-cm front separation, and gel stained with col-
loidal CBB G (B1131; Sigma). Gel regions corresponding to
VVL andVVL columnswere analyzed at aMS facility (Cen-
tro de Estudios Químicos y Biolo´gicos por Espectrometría de
Masa, Universidad de Buenos Aires, Argentina). Samples were
digested with trypsin, and peptides were purified by nano-LC-
MS/MS in aQ-Exactivemass spectrometer (ThermoFisher Sci-
entific). A H2O/acetonitrile gradient at a flow rate of 33 nl/min
was used with a C18 2-mm EASY-Spray Accucore (ES801;
ThermoFisher Scientific) coupled to Q-Exactive–Orbitrap
hybrid spectrometer (ThermoFisher Scientific). The top 12
peaks in each cycle were fragmented by the data-dependent
MS2method. Data analysis was performed using the Proteome
Discoverer software program, version 1.4. Based on the results,
the following criterion was established. Proteins were consid-
ered O-GalNAc–glycosylated for those hits in the VVL col-
umn having  2 high-quality peptides and peptide spectrum
matches ratio (PSM ratio) of 3. PSM ratio was calculated as
PSM for a hit identified in theVVL columndivided by PSMof
the same hit in theVVL column. Thus, the criterionwas PSM
ratio (VVL column PSM/VVL column PSM) of3.
Prediction of LMNB1O-GalNAc glycosylation
TheLMNB1 amino acid sequence (UniProtKB-P20700 LMNB1_
HUMAN) was analyzed for O-GalNAc glycosylation site pre-
diction using the bioinformatic NetOGlyc 4.0 server
(cbs.dtu.dk/services/NetOGlyc/).4
O-GalNAc over-glycosylation of nuclei expressing LMNB1
HeLa cells (80% confluence) were transfected for 2 h using
LipofectamineTransfectionReagent (ThermoFisher Scientific)
with mCherry–LMNB1–10 plasmid (55069; Addgene). Trans-
fected cells were incubated for 24 h at 37 °C, harvested, and
subjected to subcellular fractionation for nuclei purification.
Purified nuclei were incubated without or with UDP-GalNAc
in glycosylation buffer for 1 h at 37 °C as described above,
washed with PBS, seeded onto polylysine-coated coverslips,
and subjected to fluorescence microscopy.
O-GalNAc/LMNB1 correlation analysis
HeLa-purified nuclei and OG nuclei expressing Cherry–
LMNB1 were stained with biotin–VVL (1:1,000) or biotin–
WGA (1:500) (control) and then with Alexa 488–streptavidin
(1:2,000). Samples were imaged by confocalmicroscopy (model
FV-1200, Olympus) using PlanApoN objective. Images were
acquired in constant acquisition settings and sequential mode
to avoid bleed-through between channels and processed using
the Fiji program. Background was subtracted; a Gaussian filter
with 2was applied, and correlation analysis of green (Alexa
488/channel 1) and red (cherry/channel 2) channels was per-
formed. Intensity profiles of the two channels were obtained
using BAR extension 1.1.6. Fluorograms and Pearson’s correla-
tion coefficients were obtained by the JaCoP extension, using
Costes’ automated thresholding method.
Acceptor photobleaching/FRET assay
HeLa nuclei and OG nuclei were treated as indicated above.
FRET assaywas performed using a confocalmicroscope (model
FV-1200, Olympus) with PlanApoN objective. Images were
acquired in constant acquisition settings and sequential mode
before and after bleaching. Sampleswere subjected to bleaching
for 2 ms in the acceptor channel (Cherry–LMNB1) receiving
complete photobleaching. The area of bleaching region was
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constant. Change of fluorescence in donor channel (Alexa 488)
was evaluated after acceptor photobleaching, and FRET index
for each pixel was calculated as shown in Equation 1,
FRET index
1
donor fluorescence in presence of acceptor
donor fluorescence in absence of acceptor
(Eq. 1)
Mean FRET index (n 5) in the bleaching area was quantified
for each condition. Images were processed using Fiji and FV10-
ASW 3.1 software programs.
Statistical analysis
Means were compared by Mann-Whitney test or unpaired t
test, using GraphPad Prism 5. Standard error of themean (S.E.)
is shown as error bars in figures. Statistical significance of dif-
ferences between means is indicated by * (p  0.05); ** (p 
0.01); *** (p 0.001), or ns (not significant).
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